Matches in DBpedia 2016-04 for { <http://wikidata.dbpedia.org/resource/Q6053320> ?p ?o }
Showing triples 1 to 32 of
32
with 100 triples per page.
- Q6053320 subject Q16391411.
- Q6053320 subject Q8616541.
- Q6053320 subject Q8616578.
- Q6053320 abstract "The Society for Immunotherapy of Cancer (SITC), previously known as The International Society for Biological Therapy of Cancer (iSBTc)[1] is a professional society of influential scientists, academicians, researchers, clinicians, government representatives, and industry leaders from around the world dedicated to improving cancer patient outcomes by advancing the science and application of cancer immunotherapy. Currently, SITC has more than 600 members representing 17 medical specialties and are engaged in research and treatment of at least a dozen types of cancer.Through emphasis on high-caliber scientific meetings, dedication to education and outreach activities, focus on initiatives of major importance to the field, and commitment to collaborations with like-minded organizations and patient advocacy groups, SITC brings together all aspects of the cancer immunology and immunotherapy community in an effort to make cancer immunotherapy one of the four standards of care and the word “cure” a reality for cancer patients living with this disease. The goals of SITC are directed towards the rapid dissemination of information in these areas to expedite the safe transfer of both basic and applied research to the clinical setting.Core ValuesInteraction - Facilitate the exchange of information and education among basic and translational researchers, clinicians, young investigators, societies and groupssharing the mission of SITCInnovation - Challenge the thinking and seek the best research in the development of cancer immunotherapy Translation - Facilitate the transfer of cancer immunology and immunotherapy research from the bench to the clinic and backLeadership - Define what is new and important and effectively communicate it to all relevant stakeholders".
- Q6053320 formationYear "1984".
- Q6053320 headquarter Q37836.
- Q6053320 wikiPageExternalLink sitc-meetings.
- Q6053320 wikiPageExternalLink www.immunotherapyofcancer.org.
- Q6053320 wikiPageExternalLink about.
- Q6053320 wikiPageExternalLink www.sitcancer.org.
- Q6053320 wikiPageWikiLink Q16391411.
- Q6053320 wikiPageWikiLink Q2012719.
- Q6053320 wikiPageWikiLink Q37836.
- Q6053320 wikiPageWikiLink Q42240.
- Q6053320 wikiPageWikiLink Q8616541.
- Q6053320 wikiPageWikiLink Q8616578.
- Q6053320 formation "1984".
- Q6053320 headquarters Q37836.
- Q6053320 leaderName "Francesco Marincola, MD, Sidra Medical and Research Center".
- Q6053320 leaderTitle "President".
- Q6053320 name "Society for Immunotherapy of Cancer".
- Q6053320 type Organization.
- Q6053320 type Agent.
- Q6053320 type Organisation.
- Q6053320 type Agent.
- Q6053320 type SocialPerson.
- Q6053320 type Thing.
- Q6053320 type Q43229.
- Q6053320 comment "The Society for Immunotherapy of Cancer (SITC), previously known as The International Society for Biological Therapy of Cancer (iSBTc)[1] is a professional society of influential scientists, academicians, researchers, clinicians, government representatives, and industry leaders from around the world dedicated to improving cancer patient outcomes by advancing the science and application of cancer immunotherapy.".
- Q6053320 label "International Society for Biological Therapy of Cancer".
- Q6053320 homepage www.sitcancer.org.
- Q6053320 name "Society for Immunotherapy of Cancer (SITC)".